medicine against heart attack
Type 2 diabetes - patients could take
THIS medicine to protect against heart attack
TYPE 2 diabetes can increase the risk of heart attack and stroke
- but experts believe
Type 2 diabetes: Aspirin could reduce risk of
heart attack
Taking aspirin twice a day - rather than the
currently recommended once daily - could protect type 2 diabetics from potentially deadly episodes
including heart attack and stroke.
Cardiovascular
disease, also known as heart disease or CVD, is the leading cause of illness
and death in people with type 2 diabetes.
Aspirin,
a drug which is available over the counter, has anti-clotting abilities.
Guidelines usually recommend people with type 2 diabetes take the drug once a day to reduce
the risk of stroke.
The
pill works by ensuring blood platelets are less likely to form clots which can
lead to a stroke or heart attack.
GETTYType 2 diabetes: Aspirin could reduce risk of
heart attack
However,
studies have suggested that a once-daily aspirin does not work properly when
platelet turnover is increased, as seen in people with type 2 diabetes.
Dr
Liv Vernstroem and colleagues from Aarhus University Hospital in Denmark
investigated whether the effect of aspirin declines during the 24 hour dosing
interval in 21 people with type two diabetes without CVD.
They
matched the participants to healthy controls after a week of low-dose aspirin treatment.
They
also looked at whether patients with type 2 diabetes had increased platelet
turnover compared to the control group.
Blood
samples were taken at the start of the study, and one hour after intake of 75mg
of aspirin to look at how the participants' platelet function responded to
aspirin.
GETTYType 2 diabetes: Aspirin could reduce risk of
heart attack
Type 2 diabetes
patients could benefit from taking aspirin to reduce heart attack risk
The
participants were then treated for six days with once-daily aspirin.
Researchers
found that aspirin-treated patients with type 2 diabetes without a history of
CVD had an increase in platelet aggregation - clotting - through the standard
24 hour dosing interval.
This
was also observed in the control group.
The
researchers said the findings show the ability of aspirin to prevent blood
clotting had declined during the dosing interval when aspirin was taken only
once a day.
Dr
Vernstroem said since patients with type 2 diabetes have an increased risk of
CVD, could benefit from a twice daily dosing of aspirin could be more
effective.
Type 2 diabetes: Aspirin could reduce risk of
heart attack
The
researchers also discovered that patients with type 2 diabetes who had not been
taking aspirin before the trial had increased platelet aggregation compared to
healthy controls.
They
said that indicates that platelets from patients with type 2 diabetes have an
increased haemostatic potential - an increased ability to form clots, perhaps
increasing the risk of CVD.
Dr
Vernstroem said: "Given that platelets in people with diabetes are
characterised by increased aggregation and increased turnover rates, our study
indicates that patients with type 2 diabetes may achieve additional benefit
from twice daily rather than once daily dosing of aspirin."
The
findings were presented at the European Association for the Study of Diabetes
(EASD) annual meeting in Lisbon, Portugal
Comments
Post a Comment